NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: AdipoLABs Regional Office Opening and University of Cyberjaya Partnership
TL;DR
AdipoLABs and Red & Blue Co. gain a strategic advantage in the ASEAN MedTech market by partnering with University of Cyberjaya to train students and validate their Pain Bot device through clinical research.
The partnership establishes a structured internship program, clinical research studies, and device donations to transfer knowledge and enhance skills in pain detection and treatment technologies.
This collaboration improves healthcare outcomes by training future professionals with advanced technologies and generating evidence-based research to benefit patients across Malaysia and ASEAN.
The inventor of the Pain Bot device, Professor Dr. Yoo Seung-mo, will serve as an adjunct professor providing hands-on training to University of Cyberjaya students.
Found this article helpful?
Share it with your network and spread the knowledge!
AdipoLABs officially opened its new Asia-Pacific regional office in Malaysia and signed two Memoranda of Understanding (MoUs) with University of Cyberjaya to advance healthcare innovation, clinical research, and talent development.
This partnership strengthens Malaysia's MedTech ecosystem, drives knowledge transfer, fosters R&D collaboration, provides industry-standard training, and enhances preventive healthcare capabilities across ASEAN.
AdipoLABs Co., Ltd. and Red & Blue Co., Ltd. from Korea, their Malaysian subsidiary AdipoLABs Healthcare (M) Sdn Bhd, and University of Cyberjaya (UoC) are the primary organizations involved.
The first MoU includes a comprehensive six-month internship program for physiotherapy students, hands-on training with AdipoLABs' Pain Bot device, technical operations support from biomedical engineering students, strategic client engagement initiatives, and collaborative clinical research studies.
The second MoU focuses on knowledge transfer and medical device donation, specifically involving AdipoLABs Malaysia donating a Pain Bot unit to University of Cyberjaya to enhance student training in pain detection and treatment technology.
Students will gain invaluable real-world experience through six-month internships, hands-on expertise with cutting-edge medical devices like Pain Bot, potential job opportunities, and involvement in clinical research that could lead to publications in reputable journals.
Pain Bot is AdipoLABs' medical device for pain detection and treatment, which students will gain hands-on experience with, enhancing their skills in innovative musculoskeletal pain management methods.
The announcement was made on December 4, 2025, and the new regional office is located in Petaling Jaya, Malaysia, serving as AdipoLABs' Asia-Pacific headquarters.
AdipoLABs is a Ministry of Health (MOH)-registered medical-device establishment under the Medical Device Authority (MDA), providing proven regulatory credibility and reinforcing University of Cyberjaya's evidence-based research ambitions.
Company leadership expects to expedite adoption of advanced healthcare solutions, improve patient outcomes worldwide, cultivate local talent, drive Malaysian healthcare innovation, and create a blueprint for international healthcare partnerships.
Curated from NewMediaWire
